title: Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota.
abstract: OBJECTIVE
  To determine the incidence rates of open-angle glaucoma (OAG) in Olmsted County, MINNESOTA:
  
  
  METHODS
  Retrospective population-based estimate of incidence.
  
  
  METHODS
  From the medical histories of 60,666 residents of Olmsted County, Minnesota, who had ocular diagnoses during the study period, 114 subjects with newly diagnosed OAG were identified.
  
  
  METHODS
  The database of the Rochester Epidemiology Project was used to identify all Olmsted County residents with a coded diagnosis of OAG, glaucoma suspect, or ocular hypertension during the period 1965 to 1980. Subjects newly diagnosed with and treated for OAG who also had documented clinical evidence of elevated intraocular pressure, optic nerve damage, and/or visual field loss consistent with glaucoma were included as incident cases. Population data for Olmsted County were drawn from United States Census data. Crude incidence data were adjusted to the age and gender distribution of the 1990 United States white population.
  
  
  METHODS
  Estimated incidence rates of OAG.
  
  
  RESULTS
  The overall age- and gender-adjusted annual incidence rate of OAG in a predominantly Caucasian population is conservatively estimated to be 14.5 per 100,000 population. The rates increased with age from 1.6 in the fourth decade of life to 94.3 in the eighth decade. There was no significant difference in incidence by gender. The average annual rate of OAG in the last 2 years of the study was 27.7 compared with 12.3 before 1979. This difference is suggestive of the effect of the introduction of a new medical therapy (timolol) for OAG during the last 2 years.
  
  
  CONCLUSIONS
  The incidence rates of OAG increase markedly with advancing age, and screening efforts should be targeted at both men and women in the older age groups. The advent of new diagnostic and therapeutic modalities can have an effect on incidence rates.
authors.affiliation: Department of Ophthalmology, Mayo Clinic and Mayo Foundation, 200 First Street NW, Rochester, Minnesota MN44905, USA.
authors.forename: E O
authors.initials: EO
authors.lastname: Schoff
authors.forename: M G
authors.initials: MG
authors.lastname: Hattenhauer
authors.forename: H H
authors.initials: HH
authors.lastname: Ing
authors.forename: D O
authors.initials: DO
authors.lastname: Hodge
authors.forename: R H
authors.initials: RH
authors.lastname: Kennedy
authors.forename: D C
authors.initials: DC
authors.lastname: Herman
authors.forename: D H
authors.initials: DH
authors.lastname: Johnson
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D005902:Glaucoma, Open-Angle / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D008910:Minnesota / Q000453:epidemiology; D012189:Retrospective Studies; D017678:Sex Distribution; D014786:Vision Disorders / Q000453:epidemiology; D014794:Visual Fields